Selenium Attenuates Radiation Colitis by Regulating cGAS‐STING Signaling DOI Creative Commons
Xuefeng Qian, Haoqiang Lai,

Haimei Zhang

et al.

Advanced Science, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 30, 2024

Abstract Radiation colitis is one of the most common complications in patients undergoing pelvic radiotherapy and there no effective treatment clinic. Therefore, searching for agents radiation urgently needed. Herein, it found that essential element selenium (Se) protective against through inhibiting X‐ray‐induced apoptosis, cell cycle arrest, inflammation with involvement balancing generation reactive oxygen species after irradiation. Mechanistically, Se, especially nanoparticles (SeNPs), induced selenoprotein expression then functioned to effectively restrain DNA damage response, which reduced intestinal injury. Additionally, SeNPs also restrained cyclic GMP‐AMP synthas (cGAS)‐ stimulator interferon genes (STING)‐TBK1‐IRF3 signaling pathway cascade, thereby blocking transcription inflammatory cytokine gene, IL‐6 TNF‐α, thus alleviating inflammation. Moreover, inducing expression, such as GPX4, vivo can regulate microenvironment immunity gut microbiota attenuate radiation‐induced by oxidative stress maintaining homeostasis. Together, these results unravel a previously unidentified modulation role but suppressing cGAS‐STING‐TBK1‐IRF3 cascade.

Language: Английский

Advances in chitosan-based drug delivery systems: A comprehensive review for therapeutic applications DOI

Ammar Haider,

Shabana I. Khan, Dure Najaf Iqbal

et al.

European Polymer Journal, Journal Year: 2024, Volume and Issue: 210, P. 112983 - 112983

Published: March 26, 2024

Language: Английский

Citations

52

Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer DOI Creative Commons
Hua Su, Chao Peng, Yang Liu

et al.

Frontiers in Cell and Developmental Biology, Journal Year: 2024, Volume and Issue: 12

Published: March 18, 2024

The global challenge posed by cancer, marked rising incidence and mortality rates, underscores the urgency for innovative therapeutic approaches. PI3K/Akt signaling pathway, frequently amplified in various cancers, is central regulating essential cellular processes. Its dysregulation, often stemming from genetic mutations, significantly contributes to cancer initiation, progression, resistance therapy. Concurrently, ferroptosis, a recently discovered form of regulated cell death characterized iron-dependent processes lipid reactive oxygen species buildup, holds implications diseases, including cancer. Exploring interplay between dysregulated pathway ferroptosis unveils potential insights into molecular mechanisms driving or inhibiting ferroptotic cells. Evidence suggests that may sensitize cells induction, offering promising strategy overcome drug resistance. This review aims provide comprehensive exploration this interplay, shedding light on disrupting enhance as an alternative route inducing improving treatment outcomes.

Language: Английский

Citations

26

Unveiling the potential effects of resveratrol in lung cancer treatment: Mechanisms and nanoparticle-based drug delivery strategies DOI Open Access

Behnam Najafiyan,

Zahra Bokaii Hosseini,

Samar Esmaelian

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2024, Volume and Issue: 172, P. 116207 - 116207

Published: Jan. 31, 2024

Lung cancer ranks among the most prevalent forms of and remains a significant factor in cancer-related mortality across world. It poses challenges to healthcare systems society as whole due its high incidence, rates, late-stage diagnosis. Resveratrol (RV), natural compound found various plants, has shown potential nanomedicine for lung treatment. RV varied effects on cells, including promoting apoptosis by increasing pro-apoptotic proteins (Bax Bak) decreasing anti-apoptotic (Bcl-2). also hinders cell proliferation influencing important signaling pathways (MAPK, mTOR, PI3K/Akt, Wnt/β-catenin) that govern progression. In addition, acts potent antioxidant, diminishing oxidative stress safeguarding cells against DNA damage. However, using alone treatment drawbacks, such low bioavailability, lack targeting ability, susceptibility degradation. contrast, nanoparticle-based delivery address these limitations hold promise improving outcomes cancer; nanoparticle formulations offer advantages improved drug delivery, increased stability, controlled release, targeted cells. This article will provide an overview cancer, explore therapeutic agent, discuss benefits highlight nanoparticles treatment, cancer. By optimizing clinical application, future studies aim enhance overall improve prognosis patients.

Language: Английский

Citations

24

Dendrimer/metal-phenolic nanocomplexes encapsulating CuO2 for targeted magnetic resonance imaging and enhanced ferroptosis/cuproptosis/chemodynamic therapy by regulating the tumor microenvironment DOI

Haoyu Huang,

Honghua Guo,

Junjie Liu

et al.

Acta Biomaterialia, Journal Year: 2024, Volume and Issue: 183, P. 252 - 263

Published: May 25, 2024

Language: Английский

Citations

21

Copper in colorectal cancer: From copper‐related mechanisms to clinical cancer therapies DOI Creative Commons
Yuhong Wang, Pei Pei, Kai Yang

et al.

Clinical and Translational Medicine, Journal Year: 2024, Volume and Issue: 14(6)

Published: May 28, 2024

Abstract Copper, a trace element and vital cofactor, plays crucial role in the maintenance of biological functions. Recent evidence has established significant correlations between copper levels, cancer development metastasis. The strong redox‐active properties offer both benefits disadvantages to cells. intestinal tract, which is primarily responsible for uptake regulation, may suffer from an imbalance homeostasis. Colorectal (CRC) most prevalent primary tract aggressive malignant disease with limited therapeutic options. Current research focused on relationship CRC. Innovative concepts, such as cuproplasia cuproptosis, are being explored understand copper‐related cellular proliferation death. Cuproplasia regulation cell that mediated by enzymatic nonenzymatic copper‐modulated activities. Whereas, cuproptosis refers death induced excess via promoting abnormal oligomerisation lipoylated proteins within tricarboxylic acid cycle, well diminishing levels iron‐sulphur cluster proteins. A comprehensive understanding mechanisms offers new avenues CRC treatment. In this review, we summarise evolving molecular mechanisms, ranging intracellular concentrations discovered, discuss pathogenesis, progression potential therapies Understanding will help provide theoretical foundation innovative treatment strategies management.

Language: Английский

Citations

21

Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives DOI Creative Commons
Chenliang Zhang, Tingting Huang, Liping Li

et al.

Journal of Hematology & Oncology, Journal Year: 2024, Volume and Issue: 17(1)

Published: Aug. 16, 2024

Cuproptosis is a newly identified form of cell death induced by excessive copper (Cu) accumulation within cells. Mechanistically, cuproptosis results from Cu-induced aggregation dihydrolipoamide S-acetyltransferase, correlated with the mitochondrial tricarboxylic acid cycle and loss iron–sulfur cluster proteins, ultimately resulting in proteotoxic stress triggering death. Recently, has garnered significant interest tumor research due to its potential as crucial therapeutic strategy against cancer. In this review, we summarized cellular molecular mechanisms relationship other types Additionally, reviewed current drugs or strategies available induce cells, including Cu ionophores, small compounds, nanomedicine. Furthermore, targeted metabolism specific regulatory genes cancer therapy enhance sensitivity cuproptosis. Finally, discussed feasibility targeting overcome chemotherapy immunotherapy resistance suggested future directions. This study that could open new avenues for developing therapy.

Language: Английский

Citations

21

A mitochondria-interfering nanocomplex cooperates with photodynamic therapy to boost antitumor immunity DOI
Zhijie Zhang,

Qingfu Zhao,

Qingqing Xu

et al.

Biomaterials, Journal Year: 2025, Volume and Issue: 317, P. 123094 - 123094

Published: Jan. 7, 2025

Language: Английский

Citations

2

Advances in cuproptosis harnessing copper-based nanomaterials for cancer therapy DOI
Yuanying Yang, Chen Dong, Xuehua Ma

et al.

Journal of Materials Chemistry B, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

This review discusses the recent developments in copper-based nanomaterials that utilize copper-induced cell death, categorized by materials systems, while highlighting limitations of current cuproptosis related nanomaterials.

Language: Английский

Citations

2

Solubility of digitoxin in supercritical CO2: Experimental study and modeling DOI Creative Commons
Mohammad Reza Sheikhi‐Kouhsar, Hamidreza Bagheri,

Fahad Alsaikhan

et al.

European Journal of Pharmaceutical Sciences, Journal Year: 2024, Volume and Issue: 195, P. 106731 - 106731

Published: Feb. 20, 2024

In this communication, the solubility of digitoxin drug in supercritical CO

Language: Английский

Citations

14

Circular RNAs in the KRAS pathway: Emerging players in cancer progression DOI
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal

et al.

Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 256, P. 155259 - 155259

Published: March 11, 2024

Language: Английский

Citations

12